Market revenue in 2023 | USD 83.8 million |
Market revenue in 2030 | USD 108.7 million |
Growth rate | 3.8% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.85% in 2023. Horizon Databook has segmented the Israel formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
The outsourcing market for formulation development in Israel is expected to experience significant growth during the forecast period. This is due to the country's supporting research and innovation ecosystem, which is home to 1,500 active life sciences companies.
Israel become a hub for novel medical and health technologies, with a strong infrastructure in bioengineering, paramedical research, and medical capabilities that enable a wide range of scientific research.
In addition, Israel's world-class facilities are recognized globally, and it maintains frequent contact with major scientific and medical research centers. The country has given rise to numerous pharmaceutical companies, R&D centers, biotechnology firms, and academic institutions, making it a leader in the drug discovery and development industry.
Horizon Databook provides a detailed overview of country-level data and insights on the Israel formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Israel formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account